Zargar A H, Bashir M I, Khan A R, Masoodi S R, Laway B A, Wani A I, Dar F A
Department of Endocrinology, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, Kashmir, India.
Exp Clin Endocrinol Diabetes. 2000;108(6):397-400. doi: 10.1055/s-2000-8135.
Alterations in trace elements and mineral homeostasis have been documented both in insulin-dependent diabetes mellitus and non-insulin dependent diabetes mellitus. No data are available about trace elements in fibrocalculous pancreatic diabetes, a unique form of secondary diabetes mellitus. This study evaluated the plasma concentrations of copper, zinc and magnesium in this form of diabetes. Twenty-five patients (9 men and 16 women) with fibrocalculous pancreatic diabetes and 25 healthy non-diabetic subjects (16 men and 9 women) were studied. Patients with overt nephropathy were excluded. Plasma copper, zinc, and magnesium levels were analyzed using a GBC 902 double beam absorption spectrophotometer. The effect of glycemic control, microalbuminuria, sex and modality of treatment received on the plasma levels of copper, zinc and magnesium was assessed. Results of the study revealed that plasma copper, zinc, and magnesium levels were comparable between patients with fibrocalculous pancreatic diabetes and control subjects. Plasma copper levels were significantly higher in patients with controlled diabetes (16.15 +/- 0.67 micromol L(-1)) as compared to those with uncontrolled diabetes (13.75 +/- 0.61 micromol L(-1)) and healthy controls (13.91 +/- 0.55 micromol L(-1)). This merits further investigation. Microalbuminuria, modality of treatment received and sex did not influence the levels of these elements in fibrocalculous pancreatic diabetes.
胰岛素依赖型糖尿病和非胰岛素依赖型糖尿病患者均有微量元素及矿物质稳态改变的记录。关于纤维钙化性胰腺糖尿病(一种独特的继发性糖尿病)患者的微量元素情况,目前尚无相关数据。本研究评估了此类糖尿病患者血浆中铜、锌和镁的浓度。研究对象为25例纤维钙化性胰腺糖尿病患者(9例男性,16例女性)和25名健康非糖尿病受试者(16例男性,9例女性)。排除明显肾病患者。使用GBC 902双光束吸收分光光度计分析血浆铜、锌和镁水平。评估血糖控制、微量白蛋白尿、性别及所接受治疗方式对血浆铜、锌和镁水平的影响。研究结果显示,纤维钙化性胰腺糖尿病患者与对照受试者的血浆铜、锌和镁水平相当。与未控制糖尿病患者(13.75±0.61 μmol/L(-1))及健康对照者(13.91±0.55 μmol/L(-1))相比,血糖控制良好的患者血浆铜水平显著更高(16.15±0.67 μmol/L(-1))。这值得进一步研究。微量白蛋白尿、所接受治疗方式及性别均不影响纤维钙化性胰腺糖尿病患者这些元素的水平。